Trifluoroacetic acid → Tetrahydro-1,4-benzodiazepin-2-one

HRID 1253871Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1253871
C(OC([N:8]1[CH2:14][C:13]2[CH:15]=[CH:16][CH:17]=[CH:18][C:12]=2[NH:11][C:10](=[O:19])[CH2:9]1)=O)(C)(C)C.[F:20][C:21]([F:26])([F:25])[C:22]([OH:24])=[O:23]>C(Cl)Cl>[F:20][C:21]([F:26])([F:25])[C:22]([OH:24])=[O:23].[NH:11]1[C:12]2[CH:18]=[CH:17][CH:16]=[CH:15][C:13]=2[CH2:14][NH:8][CH2:9][C:10]1=[O:19]

Komponenten

5

Edukt 2

HCID 6422Trifluoroacetic acid2×HCID 22632545tert-Butyl 2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepine-4(5H)-carboxylate

Produkt 2

HCID 6422Trifluoroacetic acidHCID 192746Tetrahydro-1,4-benzodiazepin-2-oneAusbeute 93 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel2×

Versuchsvorschrift

To a solution of 2-oxo-1,2,3,5-tetrahydro-benzo[e][1,4]diazepine-4-carboxylic acid tert-butyl ester (300 mg, 1.14 mmol) in dry DCM (10 mL) was added trifluoroacetic acid (3.42 mL, 3 mL/mmol. The reaction mixture was stirred at r.t. for 2 h. After completion of the reaction as confirmed by TLC, excess of trifluoroacetic acid and DCM were removed under vacuo to afford trifluoroacetic acid salt of 1,3,4,5-tetrahydro-benzo[e][1,4]diazepin-2-one (295 mg, 93%) as a gummy solid. The crude compound was used as such without further purification for the next step.

Aufarbeitung

  1. customAfter completion of the reaction
  2. customwere removed under vacuo

Quellen und Nachweise

ORD-Eintrag
ord-5005d267f92b4854a41c767f24026e46
Quelldatensatz
uspto-grants-2013_06
Patentnummer
US08455479B2

Notizen zur Reaktion

Wird geladen…